74 related articles for article (PubMed ID: 24307601)
1. Dose enhancement by various nanoparticles in prostate brachytherapy.
Ghorbani M; Bakhshabadi M; Golshan A; Knaup C
Australas Phys Eng Sci Med; 2013 Dec; 36(4):431-40. PubMed ID: 24307601
[TBL] [Abstract][Full Text] [Related]
2. A Monte Carlo study on tissue dose enhancement in brachytherapy: a comparison between gadolinium and gold nanoparticles.
Bahreyni Toossi MT; Ghorbani M; Mehrpouyan M; Akbari F; Sobhkhiz Sabet L; Soleimani Meigooni A
Australas Phys Eng Sci Med; 2012 Jun; 35(2):177-85. PubMed ID: 22700179
[TBL] [Abstract][Full Text] [Related]
3. Photon activation therapy: a Monte Carlo study on dose enhancement by various sources and activation media.
Bakhshabadi M; Ghorbani M; Meigooni AS
Australas Phys Eng Sci Med; 2013 Sep; 36(3):301-11. PubMed ID: 23934379
[TBL] [Abstract][Full Text] [Related]
4. A Monte Carlo evaluation of dose enhancement by cisplatin and titanocene dichloride chemotherapy drugs in brachytherapy with photon emitting sources.
Yahya Abadi A; Ghorbani M; Mowlavi AA; Knaup C
Australas Phys Eng Sci Med; 2014 Jun; 37(2):327-36. PubMed ID: 24706342
[TBL] [Abstract][Full Text] [Related]
5. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
Pickett B; Pouliot J
Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
[TBL] [Abstract][Full Text] [Related]
6. Tumor dose enhancement by nanoparticles during high dose rate (192)Ir brachytherapy.
Zabihzadeh M; Arefian S
J Cancer Res Ther; 2015; 11(4):752-9. PubMed ID: 26881513
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of dose enhancement in presence of gold nanoparticles in eye brachytherapy by
Rezaei H; Zabihzadeh M; Ghorbani M; Goli Ahmadabad F; Mostaghimi H
Australas Phys Eng Sci Med; 2017 Sep; 40(3):545-553. PubMed ID: 28509080
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium-153 as a brachytherapy isotope.
Enger SA; Fisher DR; Flynn RT
Phys Med Biol; 2013 Feb; 58(4):957-64. PubMed ID: 23339848
[TBL] [Abstract][Full Text] [Related]
9. A Monte Carlo study of I-125 prostate brachytherapy with gold nanoparticles: dose enhancement with simultaneous rectal dose sparing via radiation shielding.
Brivio D; Nguyen PL; Sajo E; Ngwa W; Zygmanski P
Phys Med Biol; 2017 Mar; 62(5):1935-1948. PubMed ID: 28140338
[TBL] [Abstract][Full Text] [Related]
10. Study of the IsoAid ADVANTAGE (125)I brachytherapy source dosimetric parameters using Monte Carlo simulation.
Sadeghi M; Hamed Hosseini S
Appl Radiat Isot; 2010 Jan; 68(1):211-3. PubMed ID: 19762248
[TBL] [Abstract][Full Text] [Related]
11. Dose verification with Monte Carlo technique for prostate brachytherapy implants with (125)I sources.
Zhang H; Baker C; McKinsey R; Meigooni A
Med Dosim; 2005; 30(2):85-91. PubMed ID: 15922174
[TBL] [Abstract][Full Text] [Related]
12. Neutron capture therapy: a comparison between dose enhancement of various agents, nanoparticles and chemotherapy drugs.
Khosroabadi M; Ghorbani M; Rahmani F; Knaup C
Australas Phys Eng Sci Med; 2014 Sep; 37(3):541-9. PubMed ID: 24961208
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the theorectical radiation dose enhancement from nanoparticles.
Roeske JC; Nunez L; Hoggarth M; Labay E; Weichselbaum RR
Technol Cancer Res Treat; 2007 Oct; 6(5):395-401. PubMed ID: 17877427
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric parameters of the new design (103)Pd brachytherapy source based on Monte Carlo study.
Saidi P; Sadeghi M; Shirazi A; Tenreiro C
Phys Med; 2012 Jan; 28(1):13-8. PubMed ID: 21251862
[TBL] [Abstract][Full Text] [Related]
15. Influence of concentration, nanoparticle size, beam energy, and material on dose enhancement in radiation therapy.
Hwang C; Kim JM; Kim J
J Radiat Res; 2017 Jul; 58(4):405-411. PubMed ID: 28419319
[TBL] [Abstract][Full Text] [Related]
16. The use of anisotropic data in 125I prostate implants.
Fox RA; Haworth A; Mina LL
Australas Phys Eng Sci Med; 1997 Jun; 20(2):57-63. PubMed ID: 9262024
[TBL] [Abstract][Full Text] [Related]
17. Accelerated brachytherapy with the Xoft electronic source used in association with iodine, gold, bismuth, gadolinium, and hafnium nano-radioenhancers.
Mesbahi A; Rajabpour S; Smilowitz HM; Hainfeld JF
Brachytherapy; 2022; 21(6):968-978. PubMed ID: 36002350
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric characteristic of a new 125I brachytherapy source.
Sadeghi M; Khanmohammadi Z
Radiat Prot Dosimetry; 2011 Nov; 147(3):451-6. PubMed ID: 21233096
[TBL] [Abstract][Full Text] [Related]
19. Determination of dosimetric parameters for shielded
Ghorbani M; Khajetash B; Ghatei N; Mehrpouyan M; Meigooni AS; Shahraini R
Radiol Oncol; 2017 Mar; 51(1):101-112. PubMed ID: 28265239
[TBL] [Abstract][Full Text] [Related]
20. Quantifying tumor-selective radiation dose enhancements using gold nanoparticles: a monte carlo simulation study.
Zhang SX; Gao J; Buchholz TA; Wang Z; Salehpour MR; Drezek RA; Yu TK
Biomed Microdevices; 2009 Aug; 11(4):925-33. PubMed ID: 19381816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
